Many elderly in the United States face high out-of-pocket prescription drug (OOP-PD) expenditures, with elderly women being disproportionably affected. Using Medicare Current Beneficiary Survey data for 1992 to 2000, the authors examined the gender differences in OOP-PD expenditures and burden among community-dwelling elderly Medicare beneficiaries. Oaxaca-Blinder decomposition techniques were used to evaluate the contribution of observed demographic, socioeconomic, and utilization factors on the gender gap in OOP-PD expenditures and burden. Among observed characteristics, differences in utilization and supplemental insurance coverage were the major drivers of the gender gap in OOP-PD expenditures and burden. Unobservable factors contributed to the majority of the gender gap in OOP-PD expenditures.
Alecxih, L., J. Corea, D. Gross, C. Caplan, N. Brangan, and M. J. Gibson. 2001. “Reply: Methodological Biases in Estimating the Burden of Out-of-Pocket Expenses.”Health Services Research35:1365-1370.
2.
Berndt, E. R., I. M. Cockbum, D. L. Cocks, A. M. Epstein, and Z. Griliches. 1998. “Prescription Drug Prices for the Elderly.”Monthly Labor Review121(9): 23-34.
3.
Bertakis, K. D., L. J. Helms, E. J. Callahan, R. Azari, P. Leigh, and J. A. Robbins. 2001. “Patient Gender Differences in the Diagnosis of Depression in Primary Care.”Journal of Women’s Health and Gender-Based Medicine10:689-698.
4.
Bierman, A. S. and C. M. Clancy. 1999. “Women’s Health, Chronic Disease, and Disease Management: New Words and Old Music?”Women’s Health Issues9:2-17.
5.
Birnbaum, H. G., S. A. Leong, and P. E. Greenberg. 2003. “The Economics of Women and Depression: An Employer’s Perspective.”Journal of Affective Disorders74:15-22.
6.
Blehar, M. C. and D. A. Oren. 1997. “Gender Differences in Depression.”Medscape Women’s Health2:3-3.
7.
Blinder, Alan S.1973. “Wage Discrimination: Reduced Form and Structural Estimates.”Journal of Human Resources8:436-455.
8.
Blustein, J.2000. “Medicare and Drug Coverage: A Women’s Health Issue.”Women’s Health Issues10:47-53.
9.
Caplan, C.2002. “What Share of Beneficiaries’ Total Health Care Costs Does Medicare Pay?” Retrieved March 30, 2005, from http://www.aarp.org/research/medicare/outofpocket/aresearch-import-657-DD78.html
10.
Cotton, J.1988. “On the Decomposition of Wage Differentials.”Review of Economics and Statistics70:236-243.
11.
Crystal, S., R. W. Johnson, J. Harman, U. Sambamoorthi, and R. Kumar. 2000. “Out-of-Pocket Health Care Costs Among Older Americans.”Journals of Gerontology, Series B: Psychological Sciences and Social Sciences55:S51-S62.
12.
Davis, M., J. Poisal, G. Chulis, C. Zarabozo, and B. Cooper1999. “Prescription Drug Coverage, Utilization, and Spending Among Medicare Beneficiaries.”Health Affairs18:231-243.
13.
Diehr, P., D. Yanez, A. Ash, M. Hornbrook, and D. Y. Lin. 1999. “Methods for Analyzing Health Care Utilization and Costs.”Annual Review of Public Health20:125-144.
14.
Gibson, M. J. and L. A. Foley. 2000. FYI: Out-of-Pocket Spending on Prescription Drugs by Women and Men Age 65 and Older: 1999 Projections. Washington, DC: American Association of Retired Persons, Public Policy Institute.
15.
Goldman, D. P. and J. P. Smith. 2001. “Methodological Biases in Estimating the Burden of Out-of-Pocket Expenses.”Health Services Research35:1357-1365.
16.
Green, C. A. and C. R. Pope. 1999. Gender, Psychosocial Factors and the Use of Medical Services: A Longitudinal Analysis.”Social Science and Medicine48:1363-1372.
17.
Greiner, P. A., D. A. Snowdon, and L. H. Greiner. 1996. “The Relationship of Self-Rated Function and Self-Rated Health to Concurrent Functional Ability, Functional Decline, and Mortality: Findings From the Nun Study.”Journals of Gerontology, Series B: Psychological Sciences and Social Sciences51:S234-S241.
18.
Gross, D. J., L. Alecxih, M. J. Gibson, J. Corea, C. Caplan, and N. Brangan. 1999. “Out-of-Pocket Health Spending by Poor and Near-Poor Elderly Medicare Beneficiaries.”Health Services Research34:241-254.
19.
Gross, D. and N. Brangan. 1999. Out-of-Pocket Spending on Health Care by Medicare Beneficiaries Age 65 and Older: 1999 Projections (Issue Brief). Washington, DC: American Association of Retired Persons, Public Policy Institute.
20.
Heisler, M., K. M. Langa, E. L. Eby, A. M. Fendrick, M. U. Kabeto, and J. D. Piette. 2004. “The Health Effects of Restricting Prescription Medication Use Because of Cost.”Medical Care42:626-634.
21.
Jann, B. 2005. Standard Errors From the Blinder-Oaxaca Decomposition. Paper presented at the Third German Stata Users Group Meeting, Berlin, Germany.
22.
Jensen, R.2005. The New Medicare Prescription Drug Law: Issues for Enrolling Dual Eligibles Into Drug Plans. Washington, DC: Kaiser Commission on Medicaid and the Uninsured.
23.
Johnson, R. W., U. Sambamoorthi, and S. Crystal. 1999. “Gender Differences in Pension Wealth: Estimates Using Provider Data.”The Gerontologist39:320-333.
24.
Kaiser Commission on Medicaid and the Uninsured. 2003. States Respond to Fiscal Stress: Implications for Elderly Women on Medicaid. Washington, DC: Kaiser Family Foundation.
25.
Kaiser Family Foundation. 2001. Key Facts: Women and Medicare. Washington, DC: Kaiser Family Foundation.
26.
Klein, D., C. Turvey, and R. Wallace. 2004. “Elders Who Delay Medication Because of Cost: Health Insurance, Demographic, Health, and Financial Correlates.”The Gerontologist44:779-787.
27.
Lillard, L. A., J. Rogowski, and R. Kington. 1999. “Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population.”Medical Care37:926-936.
28.
Mays, J., M. Brenner, T. Neuman, J. Cubanski, and C. Claxton. 2004. Estimates of Medicare Beneficiaries’ Out-of-Pocket Drug Spending in 2006. Washington, DC: Kaiser Family Foundation.
29.
McKercher, P. L., S. D. Taylor, J. A. Lee, J. Chao, and R. N. Kumar. 2003. “Prescription Drug Use Among Elderly and Nonelderly Families.”Journal of Managed Care Pharmacy9:19-28.
30.
Moeller, J. F., G. E. Miller, and J. S. Banthin. 2004. “Looking Inside the Nation’s Medicine Cabinet: Trends in Outpatient Drug Spending by Medicare Beneficiaries, 1997 and 2001.”Health Affairs23:217-225.
31.
Mojtabai, R. and M. Olfson. 2003. “Medication Costs, Adherence, and Health Outcomes Among Medicare Beneficiaries.”Health Affairs22:220-229.
32.
Monheit, A. C. and J. P. Vistnes. 2000. “Race/Ethnicity and Health Insurance Status: 1987 and 1996.”Medical Care Research and Review57 (Suppl. 1): 11-35.
33.
Moon, M.2005. “Are Women Better Off Because of the New Medicare Drug Legislation?”Women’s Health Issues15:1-4.
34.
Moon, M. and P. Herd. 2002. A Place at the Table: Women’s Needs and Medicare Reform. New York: The Century Foundation.
35.
Neumark, D.1988. “Employers’ Discriminatory Behavior and the Estimation of Wage Discrimination.”Journal of Human Resources23:279-295.
Oaxaca, R. L. and M. R. Ransom. 1999. “Identification in Detailed Wage Decompositions.”Review of Economics and Statistics81:154-157.
38.
Older Women’s League. 2000. Medicare: Prescription for Change: Why Women Need a Medicare Drug Benefit. Washington, DC: Older Women’s League.
39.
Piette, J. D., M. Heisler, and T. H. Wagner. 2004. “Cost-related Medication Under use Among Chronically Ill Adults: The Treatments People Forgo, How Often, and Who Is at Risk.”American Journal of Public Health94:1782-1787.
40.
Poisal, J. A.2003. “Reporting of Drug Expenditures in the MCBS.”Health Care Financing Review25:23-36.
41.
Poisal, J. A. and L. Murray. 2001. “Growing Differences Between Medicare Beneficiaries With and Without Drug Coverage.”Health Affairs20:74-85.
42.
Reimers, C. W.1983. “Labor Market Discrimination Against Hispanic and Black Men.”Review of Economics and Statistics65:570-579.
43.
Rosenbach, M. L. and J. Lamphere. 1999. Bridging the Gaps Between Medicare and Medicaid: The Case of QMBs and SLMBs. Washington, DC: American Association of Retired Persons.
44.
Safran, D. G., P. Neuman, C. Schoen, M. S. Kitchman, I. B. Wilson, B. Cooper, A. Li, H. Chang, and W. H. Rogers. 2005. “Prescription Drug Coverage and Seniors: Findings From a 2003 National Survey.”Health Affairs. Available at http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w5.152
45.
Sambamoorthi, U., D. Shea, and S. Crystal. 2003. “Total and Out-of-Pocket Expenditures for Prescription Drugs Among Older Persons.”The Gerontologist43:345-359.
46.
Society for Women’s Health Research. 2004. “SWHR Answers CMS Call for Comment on MMA Implementation: Encourages Evidence-Based Formularies and Recognition of Sex Differences.” Retrieved June 9, 2005, from http://www.womenshealthresearch.org/press/releases/100404.htm
47.
StataCorp. 2004. Stata Statistical Software. College Station, TX: StataCorp.
48.
Steinberg, E. P., B. Gutierrez, A. Momani, J. A. Boscarino, P. Neuman, and P. Deverka. 2000. “Beyond Survey Data: A Claims-Based Analysis of Drug Use and Spending by the Elderly.”Health Affairs19:198-211.
49.
Stuart, B., F. Ahern, V. Rabatin, and A. Johnson. 1991. “Patterns of Outpatient Prescription Drug Use Among Pennsylvania Elderly.”Health Care Financing Review12:61-72.
50.
U. S. Department of Health and Human Services. 2002. “Summary Historical Figures and Federal Register References for the HHS Poverty Guidelines Since 1982.” Retrieved December 16, 2002, from http://aspe.hhs.gov/poverty/figures-fed-reg.htm
51.
U. S. Department of Labor, Bureau of Labor Statistics. 2003. Consumer Price Index. Retrieved April 3, 2003, from http://www.bls.gov/cpi/home.htm%23data
52.
Verbrugge, L. M.1984. “A Health Profile of Older Women With Comparisons to Older Men.”Research on Aging6:291-322.
53.
Verbrugge, L. M. and R. P. Steiner. 1985. “Prescribing Drugs to Men and Women.”Health Psychology4:79-98.
